4 completed, 1 recruiting. 5 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 4, Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Helse Sor-Ost: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients Nicotinamide Riboside, Placebo - Breast Cancer, Metastatic Breast Cancer | Phase 2 | Recruiting | University Hospital, Akershus | 60 | 2023-03-16 | 2023-03-17 |
| Phase IIb Study Evaluating Immunogenic Chemotherapy Combined With Ipilimumab and Nivolumab in Breast Cancer Ipilimumab, Nivolumab, Pegylated liposomal doxorubicin - Breast Cancer, Hormone Receptor Positive Tumor | Phase 2 | Completed | Oslo University Hospital | 82 | 2018-01-21 | 2024-10-15 |
| Effect of Exercise After Heart Transplantation Interval-based aerobic exercise - Heart Transplantation | Phase 2 | Completed | Oslo University Hospital | 51 | 2009-10-01 | 2013-02-20 |
| Phase II Cancer Vaccine Trial for Patients With Follicular Lymphoma Radiotherapy, rituximab and DC - Follicular Lymphoma | Phase 2 | Completed | Oslo University Hospital | 14 | 2009-10-01 | 2014-10-23 |
| Ibedrift- A Trial Comparing a New Approach to Musculoskeletal Pain Consisting of Education and Peer Involvement to Treatment as Usual Information and Peer advisor, Information, peer advisor and fast referral - Neck Pain Musculoskeletal, Back Pain Lower Back | Phase 2 / Phase 3 | Completed | NORCE Norwegian Research Centre AS | 2097 | 2008-09-01 | 2015-02-26 |
Breast Neoplasms (2) · Cardiotoxicity (1) · Heart Failure (1) · Low Back Pain (1) · Lymphoma, Follicular (1) · Motor Activity (1) · Musculoskeletal Pain (1) · Neoplasms (1)
Cyclophosphamide (1) · Exercise (1) · Ipilimumab (1) · Nivolumab (1) · Radiotherapy (1) · Rituximab (1) · liposomal doxorubicin (1) · nicotinamide-beta-riboside (1)
Norway (5) · Belgium (1)
Aage Indahl, Ph.d (1) · Arne Kolstad, MD, PhD (1) · Jon Amund Kyte (1) · Lars Gullestad, MD,PhD,Prof. (1)
PMID 22659939, PMID 22900793, PMID 23185084, PMID 25293773, PMID 32518655, PMID 32620163, PMID 38242720